Top brokers name 3 ASX shares to sell today

Ardent Leisure Group (ASX:AAD) shares are one of three rated as sells by top brokers this week. Here's why…

| More on:
a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

On Wednesday I looked at three shares that had been given buy ratings this week by top brokers following the release of their respective results or updates.

Not all shares have been so fortunate, though. Three shares that have been given sell ratings this week are listed below:

ALS Ltd (ASX: ALQ)

According to a note out of Deutsche Bank, it has retained its sell rating and $6.87 price target on the shares of this provider of testing and analytical laboratory services following the release of its guidance at its annual general meeting. ALS' management expects underlying half-year net profit after tax from continuing operations to be in the range of $85 million and $90 million, compared to the broker's estimate of $85 million. Deutsche downgraded ALS to a sell rating in May due to its belief that it wouldn't be able to maintain its above-industry growth in the medium term. While I wouldn't necessarily be a seller of its shares if I owned them, I wouldn't be a buyer unless there was a decent pullback.

Ardent Leisure Group (ASX: AAD)

Analysts at UBS have retained their sell rating and $1.75 price target on this entertainment company's shares following the release of its trading update. The broker doesn't appear to have seen anything in the update to warrant a change of recommendation and believes that the Main Event brand needs to improve its margins before a potential U.S. IPO is an option. UBS' price target implies potential downside of almost 7%. I wouldn't be a seller of Ardent Leisure shares at this point and believe there's far more upside potential than downside risk now.

Regis Resources Limited (ASX: RRL)

A note out of Citi reveals that its analysts have retained their sell rating and cut the price target on the gold miner's shares to $3.85 following the release of its production update. The broker appears concerned by the company's rising costs and flat production guidance for FY 2019. And although the broker thinks Regis is a quality miner, it feels its shares are overvalued at present. I would have to agree with Citi on this one and believe that investors that are bullish on gold would be better with one of its cheaper rivals.

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Share Market News

Businessman smiles with arms outstretched after receiving good news.
Share Gainers

Here are the top 10 ASX 200 shares today

It was another strong showing from the share market today.

Read more »

Three miners looking at a tablet.
Resources Shares

Own ASX mining shares? Experts say an upswing in commodity prices has begun

HSBC economists Paul Bloxham and Jamie Culling explain why global commodity prices are rising.

Read more »

A woman with a sad face looks to be receiving bad news on her phone as she holds it in her hands and looks down at it.
Share Fallers

Why Brambles, Lifestyle Communities, Northern Star, and Select Harvests shares are sinking

These shares are having a tough session. But why?

Read more »

A young woman sits at her desk in deep contemplation with her hand to her chin while seriously considering information she is reading on her laptop
Share Market News

Will the Reserve Bank wait for the US Fed to cut interest rates first?

Here's when AMP thinks interest rates will be cut in the US, Australia, New Zealand, Canada and the Eurozone.

Read more »

A young woman holding her phone smiles broadly and looks excited, after receiving good news.
Share Gainers

Healthco Healthcare, Medadvisor, Ramsay Health Care, and Tamboran shares are rising

These shares are having a strong session. But why?

Read more »

drug capsule opening up to reveal dollar signs signifying rising asx share price
Share Gainers

If you invested $6,000 in Mesoblast shares a month ago you'd have $15,636 now!

Mesoblast shares have been on a tear this past month. But why?

Read more »

Gold bars on top of gold coins.
Gold

Is it too late to buy gold as an investment in 2024?

Can we still take advantage of gold at new record highs?

Read more »

A female broker in a red jacket whispers in the ear of a man who has a surprised look on his face as she explains which two ASX 200 shares should do well in today's volatile climate
Mergers & Acquisitions

Wesfarmers shares baulk on fresh acquisition gossip

A healthcare company gone nowhere in a decade might be on Wesfarmers' radar.

Read more »